Neuronetics Net Worth
Neuronetics Net Worth Breakdown | STIM |
Neuronetics Net Worth Analysis
Neuronetics' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Neuronetics' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Neuronetics' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Neuronetics' net worth analysis. One common approach is to calculate Neuronetics' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Neuronetics' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Neuronetics' net worth. This approach calculates the present value of Neuronetics' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Neuronetics' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Neuronetics' net worth. This involves comparing Neuronetics' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Neuronetics' net worth relative to its peers.
Enterprise Value |
|
To determine if Neuronetics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Neuronetics' net worth research are outlined below:
| Neuronetics generated a negative expected return over the last 90 days | |
| Neuronetics has high historical volatility and very poor performance | |
| Neuronetics may become a speculative penny stock | |
| Neuronetics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 71.35 M. Net Loss for the year was (30.19 M) with profit before overhead, payroll, taxes, and interest of 49.72 M. | |
| Neuronetics currently holds about 73.7 M in cash with (32.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.71, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Neuronetics has a poor financial position based on the latest SEC disclosures | |
| Roughly 64.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Neuronetics director Robert Cascella buys 102,550 in company stock |
Neuronetics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Neuronetics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Neuronetics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 5th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 5th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Neuronetics' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Neuronetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neuronetics backward and forwards among themselves. Neuronetics' institutional investor refers to the entity that pools money to purchase Neuronetics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-03-31 | 380.5 K | Dafna Capital Management Llc | 2024-03-31 | 313.7 K | Geode Capital Management, Llc | 2024-03-31 | 286.6 K | Acadian Asset Management Llc | 2024-03-31 | 264.3 K | Marshall Wace Asset Management Ltd | 2024-03-31 | 217.6 K | Boothbay Fund Management, Llc | 2024-03-31 | 162.1 K | Hightower Advisors, Llc | 2024-03-31 | 158.2 K | Dimensional Fund Advisors, Inc. | 2024-03-31 | 147 K | Renaissance Technologies Corp | 2024-03-31 | 143.5 K | Archon Capital Management Llc | 2024-03-31 | 2.5 M | Cannell Capital Llc | 2024-03-31 | 2.5 M |
Follow Neuronetics' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 57.3 M.Market Cap |
|
Project Neuronetics' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.27) | (0.28) | |
| Return On Capital Employed | (0.32) | (0.33) | |
| Return On Assets | (0.26) | (0.27) | |
| Return On Equity | (0.88) | (0.93) |
When accessing Neuronetics' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Neuronetics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Neuronetics' profitability and make more informed investment decisions.
The data published in Neuronetics' official financial statements typically reflect Neuronetics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Neuronetics' quantitative information. For example, before you start analyzing numbers published by Neuronetics accountants, it’s essential to understand Neuronetics' liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.
Evaluate Neuronetics' management efficiency
Neuronetics has return on total asset (ROA) of (0.1537) % which means that it has lost $0.1537 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7248) %, meaning that it created substantial loss on money invested by shareholders. Neuronetics' management efficiency ratios could be used to measure how well Neuronetics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of June 2024, Return On Tangible Assets is likely to drop to -0.28. In addition to that, Return On Capital Employed is likely to drop to -0.33. At this time, Neuronetics' Net Tangible Assets are very stable compared to the past year. As of the 18th of June 2024, Other Current Assets is likely to grow to about 7.6 M, while Non Current Assets Total are likely to drop about 13.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.19 | 1.25 | |
| Tangible Book Value Per Share | 1.05 | 1.10 | |
| Enterprise Value Over EBITDA | (3.01) | (3.16) | |
| Price Book Value Ratio | 2.43 | 1.94 | |
| Enterprise Value Multiple | (3.01) | (3.16) | |
| Price Fair Value | 2.43 | 1.94 | |
| Enterprise Value | 828.8 K | 787.4 K |
The analysis of Neuronetics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Neuronetics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Neuronetics Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 1.8282 | Revenue 73.2 M | Quarterly Revenue Growth 0.121 | Revenue Per Share 2.523 | Return On Equity (0.72) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neuronetics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neuronetics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neuronetics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neuronetics time-series forecasting models is one of many Neuronetics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neuronetics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Neuronetics Earnings per Share Projection vs Actual
Neuronetics Corporate Management
| Rusty Page | Senior Quality | Profile | |
| Lisa MetznerRosas | Senior Officer | Profile | |
| Andrew Macan | Gen VP | Profile | |
| Claire Sears | VP Marketing | Profile | |
| Rick Grubbs | Senior Accounts | Profile | |
| Cory Anderson | Senior Clinical | Profile | |
| Kara Thornton | VP Director | Profile |
Additional Information and Resources on Investing in Neuronetics Stock
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 2.523 | Quarterly Revenue Growth 0.121 | Return On Assets (0.15) | Return On Equity (0.72) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.